APPLICATION
ANDA204618
TYPE
ANDA
ORIGINAL APPROVAL
2014-08-13
LATEST ACTION
2018-03-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
ETOMIDATEDiscontinued
ETOMIDATE 2MG/ML · INJECTABLE · INJECTION
Approval history
2018-03-08Labeling · Supplement 9 · standardAP
2014-08-13UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.